Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-22

Clinical Trial Update: Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children [NA]

View source ↗

Summary

A clinical trial evaluating a strict classic ketogenic diet for pediatric recurrent or refractory brain tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketogenic Diet

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Recurrent Brain Tumor, Childhood, Ketogenic Diet | NA | Status: WITHDRAWN